129 search results for: type 2 inflammation

Understanding the Pathophysiology of Pediatric <b>Type</b> <b>2</b> Inflammatory Diseases
expert video

Understanding the Pathophysiology of Pediatric Type 2 Inflammatory Diseases

Type 2 Inflammation
Prof. Oscar Palomares discusses the underlying pathophysiology of type 2 inflammation in pediatric patients with AD, asthma, or EoE.
View more
Skin Barrier, Neuroimmune Axis, and <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis - Q&As
expert video

Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis - Q&As

Dermatology
Expert insights on the plasticity of inflammation, atopic dermatitis endotypes, and dysbiosis – Audience Q&A from the ADVENT symposium at ISID 2023.
View more
How Does Protective <b>Type</b> <b>2</b> Immunity Become Harmful <b>Type</b> <b>2</b> <b>Inflammation</b>?
expert video

How Does Protective Type 2 Immunity Become Harmful Type 2 Inflammation?

Dermatology
In this video from the March 2025 ADVENT symposium in Orlando, Florida, Dr. Eric Simpson discusses how protective type 2 immunity can become dysregulated, leading to harmful type 2 inflammation. The associated inflammatory process can contribute to the pathophysiology of several dermatological diseases, including AD, PN, CSU, and BP.
View more
Skin Barrier, Neuroimmune Axis, and <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis
expert video

Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis

Dermatology
Presentations from the ADVENT symposium at the ISID 2023 meeting on the skin barrier, neuroimmune axis, and type 2 inflammation in atopic dermatitis.
View more
Targeting Underlying <b>Inflammation</b> in CRSwNP, a <b>Type</b> <b>2</b> Inflammatory Disease
expert video

Targeting Underlying Inflammation in CRSwNP, a Type 2 Inflammatory Disease

Rhinology
Professor Martin Wagenmann describes the mechanisms through which type 2 inflammation drives symptoms in patients with CRSwNP.
View more
<b>Type</b> <b>2</b> <b>Inflammation</b> in AD Manifestations in Skin and Body
expert video

Type 2 Inflammation in AD Manifestations in Skin and Body

Dermatology
Dr. Ramien discusses the role of type 2 inflammation in the pathophysiology of atopic dermatitis, and highlights the association of atopic dermatitis with systemic diseases and comorbidities.
View more
What Do We Know About <b>Type</b> <b>2</b> <b>Inflammation</b> in COPD?
expert video

What Do We Know About Type 2 Inflammation in COPD?

Pulmonology
Join global expert Dr. Michael Wechsler as he discusses type 2 inflammation in COPD.
View more
The Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Atopic Dermatitis
expert video

The Role of Type 2 Inflammation in Atopic Dermatitis

Dermatology
The impact of type 2 inflammation and barrier dysfunction in the pathogenesis of chronic disease in atopic dermatitis.
View more
The Role of <b>Type</b> <b>2</b> <b>Inflammation</b> in Skin Barrier Dysfunction in Atopic Dermatitis
expert video

The Role of Type 2 Inflammation in Skin Barrier Dysfunction in Atopic Dermatitis

Dermatology
Dr. Robert Bissonnette highlights the role of type 2 inflammation in skin barrier dysfunction in atopic dermatitis.
View more
FeNO as a Biomarker for <b>Type</b> <b>2</b> Asthma
expert video

FeNO as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Eugene Bleecker presents the utility of FeNO as a biomarker of type 2 inflammation, and its role in the disease burden of asthma.
View more
CRSwNP: A Chronic <b>Type</b> <b>2</b> Inflammatory Disease
expert video

CRSwNP: A Chronic Type 2 Inflammatory Disease

Rhinology
Prof. Peter Hellings describes how type 2 inflammation drives CRSwNP.
View more
The Cycle of <b>Inflammation</b> in Adult Asthma
interactivity

The Cycle of Inflammation in Adult Asthma

Pulmonology
Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in asthma patients
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IsraelChange country/region